Parent Compound
|
Method
|
Matrix
|
LLOQ
|
1-Methylnicotinamide
|
LC/MS/MS
|
Dog Sodium Citrate Plasma
|
|
1-Methylnicotinamide
|
LC/MS/MS
|
Human Sodium Citrate Plasma
|
|
1-Methylnicotinamide
|
LC/MS/MS
|
Human Urine
|
|
25-Hydroxycholesterol
|
LC/MS/MS
|
Tissue
|
0.1 ng/mL
|
2-Arachidonoylglycerol
(2-AG)
|
LC/MS/MS
|
Human Plasma, Blood
|
20 pg/mL
|
Acetyl-Coenzyme A
|
LC/MS/MS
|
Tumor Tissue
|
100 ng/g
|
ACTH (1-24)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
ACTH(1-24)
|
LC/MS/MS
|
K2EDTA Monkey Plasma
|
0.05 ng/mL
|
ACTH(1-24)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
0.05 ng/mL
|
ACTH(1-24)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 pg/mL
|
Adapalene
|
LC/MS/MS
|
K3EDTA Human Plasma
|
10 pg/mL
|
Adenosine
|
LC/MS/MS
|
Plasma
|
|
Agomelatine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
Aldosterone
|
LC/MS/MS
|
Human Urine
|
0.1 ng/mL
|
Aldosterone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
Alloprenanolone
|
LC/MS/MS
|
Human Plasma
|
25 pg/mL
|
Almotriptan
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Aluminum
|
ICP-MS
|
K2EDTA Human Plasma
|
|
Amino Acids
|
LC/MS/MS
|
Cell Culture Media
|
|
Amino Acids
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Amphetamine (Chiral)
|
LC/MS/MS Chiral
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
Angiotensin I
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.14 ng/mL
|
Angiotensin II
|
Immunoassay
|
K2EDTA Human Plasma
|
3.9 pg/mL
|
Anti-IIa
|
|
Human Citric Acid Plasma
|
|
Anti-Xa
|
|
Human Citric Acid Plasma
|
|
Apimostinel
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Apixaban
|
LC/MS/MS
|
Bovine Plasma
|
1 ng/mL
|
Apremilast
|
LC/MS/MS
|
Human Plasma
|
2 ng/mL
|
Apremilast
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Arachidonic Acid
|
LC/MS/MS
|
Cerebrospinal Fluid
|
0.5 ng/mL
|
Arachidonic Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
Arachidonic Acid, HETE, LTB4
|
LC/MS/MS
|
Cell Culture Media
|
0.025 µM
|
Arachidonoy Glycerol (2AG)
|
LC/MS/MS
|
Human Plasma
|
0.1 ng/mL
|
Arachidonoyl 1-Glycerol
|
LC/MS/MS
|
Cerebrospinal Fluid
|
10 pg/mL
|
Arachidonoyl 1-Glycerol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Arachidonoyl 2-Glycerol
|
LC/MS/MS
|
Cerebrospinal Fluid
|
10 pg/mL
|
Arachidonoyl 2-Glycerol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Arachidonoyl Ethanolamide
|
LC/MS/MS
|
Cerebrospinal Fluid
|
1 pg/mL
|
Arachidonoyl Ethanolamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
Arachidonoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
Arachidonoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Arginase Activity
|
Immunoassay
|
Human Serum
|
0.06 nM
|
Aripiprazole and Dehydroaripiprazole
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Artesunate
|
LC/MS/MS
|
Human Urine
|
|
Ascorbic Acid
|
LC/MS/MS
|
Human Tissue and Lavage Fluid
|
20 ng/mL
|
Atogepant
|
LC/MS/MS
|
Human Plasma
|
|
Atogepant
|
LC/MS/MS
|
Human Urine
|
|
Atorvastatin, 2-Hydroxy Atorvastatin, 4-Hydroxy Atorvastatin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
Aztreonam
|
LC/MS/MS
|
Human Plasma
|
0.2 µg/mL
|
Aztreonam
|
LC/MS/MS
|
Human Urine
|
0.2 µg/mL
|
Beclomethasone Dipropionate and its metabolites and Triamcinolone Acetonide
|
|
Dog Matrices
|
|
Betaxolol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Bile Acids
|
LC/MS/MS
|
Feces
|
10 ng/mL
|
Bile Acids
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 ng/mL
|
Bimatoprost and its Metabolite
|
LC/MS/MS
|
Human Plasma
|
|
Bimatoprost and its Metabolite
|
LC/MS/MS
|
Mini Pig K2EDTA Blood
|
|
Biotin
|
LC/MS/MS
|
Serum
|
|
Bosentan
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 ng/mL
|
Bosenton (Hydroxy Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Brinzolamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 µg/mL
|
Bromide
|
ICP-MS
|
Na Heparin Human Plasma
|
0.5 µg/mL
|
Bromocriptine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
Budesonide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 pg/mL
|
Bupremorphine and Norbuprenorphine
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
0.2 ng/mL
|
Bupremorphine and Norbuprenorphine and Naloxone
|
LC/MS/MS
|
K2EDTA Dog Plasma
|
|
Buprenorphine
|
LC/MS/MS
|
Human Urine
|
20 pg/mL
|
Buprenorphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
20 pg/mL
|
Buprenorphine Hemiadipate
|
LC/MS/MS
|
Human Urine
|
0.5 pg/mL
|
Buprenorphine Hemiadipate
|
LC/MS/MS
|
K2EDTA Dog Plasma
|
0.5 pg/mL
|
Buprenorphine Hemiadipate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 pg/mL
|
C4(7α-hydroxy-4-cholesten-3-one)
|
LC/MS/MS
|
Human Serum
|
|
C4(7α-hydroxy-4-cholesten-3-one)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Caffeine
|
LC/MS/MS
|
Human Serum
|
0.05 µg/mL
|
Caffeine
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
Caffeine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 ng/mL
|
Calcium
|
ICP/MS
|
Human Serum
|
10 µg/mL
|
Carbamazepine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 µg/mL
|
Carbamazepine (10,11-Epoxide Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.025 µg/mL
|
Carbocysteine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
30 ng/mL
|
Carfentanyl
|
LC/MS/MS
|
Animal Plasma & Tissue
|
|
Cariprazine and Metabolics
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Cariprazine and Metabolics
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
Cariprazine, Desmethyl Cariprazine and Didesmethyl Cariprazine
|
|
K2EDTA Dog Plasma
|
|
Cariprazine, Desmethyl Cariprazine and Didesmethyl Cariprazine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Cariprazine, Desmethyl Cariprazine and Didesmethyl Cariprazine
|
|
K2EDTA Rat Plasma
|
|
Catecholamine
|
LC/MS/MS
|
Human Plasma
|
10 pg/mL
|
Cebranopadol and Metabolites
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 pg/mL
|
Cefepime and Tazobactam
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
0.25 μg/ml
|
Cefepime and Tazobactam
|
LC/MS/MS
|
Human Urine
|
15 & 45 μg/mL
|
Cefiderocol
|
LC/MS/MS
|
Human BAL
|
0.005 µg/mL
|
Cefiderocol
|
LC/MS/MS
|
Human Plasma
|
0.1 µg/mL
|
Cefiderocol
|
LC/MS/MS
|
Dialysate
|
0.2 µg/mL
|
Cefiderocol
|
LC/MS/MS
|
Bovine Plasma
|
0.2 µg/mL
|
Ceftaroline
|
|
Human Plasma & Serum
|
|
Ceftaroline and Metablites
|
LC/MS/MS
|
Human Na2EDTA/NaF Plasma
|
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
Human Urine
|
0.5 µg/mL
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
Cell Culture Medium
|
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
Human Sputum
|
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
NaF/KOx Human Plasma
|
|
Cenicriviroc
|
LC/MS/MS
|
M-I, M-II protein binding
|
|
Cetirizine
|
LC/MS/MS
|
K2EDTA Minipig Plasma
|
0.025 ng/mL
|
cGAMP
|
LC/MS/MS
|
Human Plasma
|
10 ng/mL
|
Chlorogenic Acid
|
HPLC/UV
|
K2EDTA Human Plasma
|
|
Chlorpheniramine (Chiral)
|
LC/MS/MS Chiral
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
Chlorpromazine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Cilastatin & Imipenem
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
Citalopram
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Citalopram (Desmethyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Clarithromycin
|
LC/MS/MS
|
Human Plasma
|
10 ng/mL
|
Clarithromycin
|
LC/MS/MS
|
Human BAL
|
1 ng/mL
|
Colistin
|
|
Cell Media
|
|
Colistin
|
LC/MS/MS
|
Human Urine
|
10 ng/mL
|
Colistin
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 ng/mL
|
Colistin
|
LC/MS/MS
|
Rat Lung
|
100 ng/g
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
Human Urine
|
10 ng/mL
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 ng/mL
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
Rat Lung
|
100 ng/g
|
Cortisol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.25 ng/mL
|
Creatine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 µg/mL
|
Creatinine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.4 µg/mL
|
Dalbavancin
|
LC/MS/MS
|
Cell Medium
|
|
Dalbavancin
|
LC/MS/MS
|
Human Plasma
|
|
Dalbavancin
|
|
Rabbit Serum
|
|
Dapsone, N-acetyl Dapsone and N-hydroxy Dapsone
|
LC/MS/MS
|
K3EDTA Human Plasma with Ascorbic Acid
|
|
Dapsone, N-acetyl Dapsone and N-hydroxylamine Dapsone
|
LC/MS/MS
|
Human Plasma
|
|
Delafloxacin
|
LC/MS/MS
|
Human BAL
|
0.1 ng/mL
|
Dexamethasone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
DHA-Glucuronide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Digoxin
|
LC/MS/MS
|
Human Urine
|
1 ng/mL
|
Digoxin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
Dimethyl Arginine
|
LC/MS/MS
|
Human Serum
|
10 ng/mL
|
Diphenylhdramine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
Docohexaenoic Acid
|
LC/MS/MS
|
Cerebrospinal Fluid
|
0.5 ng/mL
|
Docohexaenoic Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
Donepezil and Memantine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Donepezil and Metabolites
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
Dopamine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
Doripenem
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
0.1μg/ml
|
Dronedarone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
Dronedarone (Desbutyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
Drug Antibody Conjugate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 nM
|
Dulaglutide
|
LC/MS/MS
|
Monkey Plasma
|
|
Duloxetine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Edoxaban
|
LC/MS/MS
|
Bovine Plasma
|
5 ng/mL
|
Efavirenz, Emtricitabine and Tenofovir
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Eluxadoline
|
LC/MS/MS
|
Human Protein Binding
|
|
Eluxadoline
|
LC/MS/MS
|
Human Urine
|
|
Eluxadoline
|
LC/MS/MS
|
K2EDTA Human DBS
|
|
Eluxadoline
|
LC/MS/MS
|
K2EDTA Human Dried Blood
|
0.1 ng/mL
|
Eluxadoline
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Entecavir
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
Ephedrine & Pseudoephedrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Epinephrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
Epinephrine
|
LC/MS/MS
|
Rabbit Plasma
|
|
Ethanolamides
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Factor Xa
|
Chromogenic
|
Human Serum
|
0.1 IU
|
Fatty Acid Ethanolamides
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Febtanyl
|
LC/MS/MS
|
Human Plasma
|
0.1 ng/mL
|
Febuxastat
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
FGF19
|
ELISA
|
K2EDTA Human Plasma
|
|
Flecainide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Fluoride
|
IC/ICP/MS
|
Human Serum
|
10 ng/mL
|
Fluoride
|
IC/ICP/MS
|
Rat Serum
|
|
Flupirtine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 ng/mL
|
Fluticasone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Fluticasone Propionate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
Fluticasone Propionate
|
LC/MS/MS
|
Swab
|
|
Formeterol
|
LC/MS/MS
|
NaF/K2C2O4 Human Plasma
|
0.4 pg/mL
|
Fosfomycin
|
LC/MS/MS
|
Human Urine
|
|
Fosfomycin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Free T3 and T4
|
Chemiluminescent immunoassay
|
Human Serum
|
|
Gamma Hydroxy Butyric Acid (GHB) and Gamma Amino Butyric Acid (GABA)
|
LC/MS/MS
|
Plasma
|
|
GDP Fucose
|
LC/MS/MS
|
Cell Culture Media
|
5 ng/mL
|
Glutarate, 2-Hydroxy
|
LC/MS/MS
|
Cell Culture Media
|
2.5 ng/mL
|
GRT6005 and GRT6006
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
HETE
|
LC/MS/MS
|
Human Plasma
|
100 pg/mL
|
Histamine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
Histamine Panel
|
LC/MS/MS
|
Feces
|
|
HTL0018318 and HTL0026803
|
LC/MS/MS
|
K3EDTA Human Plasma
|
0.5 ng/mL
|
Hydromorphone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
Hydroxybutyric Acid
|
LC/MS/MS
|
Human Urine
|
0.25 µg/mL
|
Idebenone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
Idebenone, Total
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
Indole
|
LC/MS/MS
|
Rat Urine
|
|
Inositol
|
LC/MS/MS
|
Human Serum
|
1 µg/mL
|
Iodine
|
ICP-MS
|
Media
|
|
Iron Sucrose
|
ICP-MS
|
Human Serum
|
1 ng/mL
|
Isosorbide-5-Mononitrate
|
LC/MS/MS
|
Blood, Urine, liver
|
|
Ivabradine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.01 ng/mL
|
Ivermectin B1a
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.4 ng/mL
|
Ivermectin B1b
|
LC/MS/MS
|
K2EDTA Human Plasma
|
40 pg/mL
|
Ketamine and Norketamine
|
LC/MS/MS
|
Human Plasma
|
1 ng/mL
|
Ketoconazole
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 µg/mL
|
Ketoprofen
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 ng/mL
|
Ketorolac
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
Kynurenines
|
LC/MS/MS
|
Human Plasma
|
1 ng/mL
|
Kynurenines
|
LC/MS/MS
|
Plasma
|
|
Lactic + Succinic Acid
|
LC/MS
|
Formulations
|
|
L-Arginine
|
LC/MS/MS
|
Heparinized Human Plasma
|
1 µg/mL
|
Latanoprost and Latanoprost Free Acid
|
LC/MS/MS
|
NaF/KOx Human Plasma
|
|
Levofloxacin
|
LC/MS/MS
|
BAL
|
|
Levofloxacin
|
LC/MS/MS
|
BAL AM Pellet
|
|
Levomilnacipran
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Levothyroxine (Free T4)
|
Immunoassay
|
Human Serum
|
0.3 ng/mL
|
Levothyroxine (Total T4)
|
LC/MS/MS
|
Human Serum
|
10 ng/mL
|
Linaclotide and MM-419447
|
LC/MS/MS
|
Human Breast Milk
|
|
Linagliptin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Liothyronine (Free T3)
|
Immunoassay
|
Human Serum
|
1 pg/mL
|
Liothyronine (Total T3)
|
LC/MS/MS
|
Human Serum
|
0.1 ng/mL
|
Lipoic Acid
|
LC/MS/MS
|
Tissue
|
0.1 ng/mL
|
Lornoxicam
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 ng/mL
|
Lovastatin , Lovastatin Hydroxy Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
L-Threonate
|
LC/MS/MS
|
Human Plasma
|
|
L-Threonic Acid
|
LC/MS/MS
|
Plasma
|
|
Lurasidone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Lysophosphatidyl acid
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
10 nM
|
Lysophosphatidylcholine
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
10 nM
|
Malonyl Coenzyme A
|
LC/MS/MS
|
Tissue
|
10 ng/g
|
Melatonin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 pg/mL
|
Melatonin and Theanine
|
LC/MS/MS
|
Human Plasma
|
|
Mercaptopurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Methotrexate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Methylamine
|
LC/MS/MS
|
Human Plasma
|
|
Methylene Blue
|
LC/MS/MS
|
Mouse Plasma
|
|
MethylHistamine
|
LC/MS/MS
|
Human Plasma
|
0.1 ng/mL
|
Methylphenidate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
Methylphenidate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
Mevalonic Acid
|
LC/MS/MS
|
Human Urine
|
5 ng/mL
|
Midazolam and 1-hydroxymidazolam
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
Mometasone Furoate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
Mometasone Furoate
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
10 pg/mL
|
Mono- & Triphosphate Nucleotides (AMP, CMP, GMP, UMP; ATP, CTP, GTP, UTP)
|
LC/MS/MS
|
Mouse Plasma
|
|
Morphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Morphine Glucuronide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 ng/mL
|
Moxifloxocin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
NAD+
|
LC/MS/MS
|
Human Red Blood Cell
|
|
NAD+
|
LC/MS/MS
|
Human Sodium Citrate Plasma
|
|
NAD+ and Metabolites
|
LC/MS/MS
|
Human Whole Blood
|
|
NAD+ and Metabolites
|
LC/MS/MS
|
Rat Whole Blood
|
|
Nafithromycin
|
LC/MS/MS
|
Human Plasma
|
|
Nafithromycin and N-desmethyl-Nafithromycin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Naloxone
|
LC/MS/MS
|
Human Urine
|
5 pg/mL
|
Naloxone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 pg/mL
|
Naloxone
|
LC/MS/MS
|
K3EDTA Human Plasma
|
2 pg/mL
|
Naloxone
|
LC/MS/MS
|
Mini Pig K2EDTA Plasma
|
2 pg/mL
|
Naloxone, Buprenorphine and Norbuprenorphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Naloxone-3-Glucuronide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 pg/mL
|
Nebivolol, Chiral
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
Nebivolol, Total
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Neurosteroids
|
LC/MS/MS
|
Human Plasma
|
|
Nicotinamide
|
LC/MS/MS
|
Human Sodium Citrate Plasma
|
|
Norbuprenorphine
|
LC/MS/MS
|
Human Urine
|
20 pg/mL
|
Norbuprenorphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
20 pg/mL
|
Norepinephrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
NR
|
LC/MS/MS
|
Human Whole Blood
|
|
NRX-2922
|
LC/MS/MS
|
Human CSF
|
|
NRX-2922
|
LC/MS/MS
|
Human Urine
|
|
NRX-2922
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
NRX-2922
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
NRX-2922
|
LC/MS/MS
|
Rat Brain
|
|
NRX-2922
|
LC/MS/MS
|
Rat CSF
|
|
Nucleotides
|
LC/MS/MS
|
Cell Culture Media
|
5 ng/mL
|
Nucleotides
|
LC/MS/MS
|
Human Serum
|
5 ng/mL
|
Oleoyl Ethanolamide
|
LC/MS/MS
|
Cerebrospinal Fluid
|
5 pg/mL
|
Oleoyl Ethanolamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.25 ng/mL
|
Oleoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
Oleoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Oligonucleotide
|
|
|
|
Oligonucleotides
|
LC/MS/MS
|
Plasma
|
|
Omadacycline
|
LC/MS/MS
|
Acidified Human Cell Pellet
|
|
Omadacycline
|
HPLC
|
Dosing Solution
|
|
Omadacycline
|
LC/MS/MS
|
Human Cell Pellet
|
|
Omadacycline
|
LC/MS/MS
|
Rat Heparin Plasma
|
|
Omadacycline
|
LC/MS/MS
|
Rat Plasma
|
|
Orotic Acid & Dihydroorotic Acid
|
LC/MS/MS
|
Human Plasma
|
5 ng/mL
|
Oxycodone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Oxymetazoline Impurity A
|
LC/MS/MS
|
Mini Pig K2EDTA Plasma
|
|
Palmitic Acid
|
LC/MS/MS
|
Tumor Tissue
|
100 ng/g
|
Palmitoyl Ethanoamide
|
LC/MS/MS
|
Cerebrospinal Fluid
|
5 pg/mL
|
Palmitoyl Ethanoamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.25 ng/mL
|
Palmitoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
Palmitoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Paroxetine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Peptide A6
|
LC/MS/MS
|
Swine Plasma
|
|
Phenylephrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
Picolinic Acid
|
|
Plasma
|
|
Piperacillin, Meropenem, & Tazobactam
|
LC/MS/MS
|
Rabbit Plasma
|
0.1 µg/mL
|
Piperacillin, Meropenem, & Tazobactam
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 µg/mL
|
Plasma Renin Activity
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL/hr
|
Platinum
|
ICP-MS
|
K2EDTA Human Plasma, Mouse Plasma & Tissue
|
1 µg/mL
|
Poloxamer 124
|
LC/MS/MS
|
Acidified K2EDTA Dog Plasma
|
|
Poloxamer 124
|
LC/MS/MS
|
K2EDTA Dog Plasma
|
1 µg/mL
|
Posaconazole
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Potassium
|
ICP-MS
|
Human Urine
|
20 µg/mL
|
Pravastatin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Pregnenolone & Allopregnanolone
|
LC/MS/MS
|
Human Plasma
|
25 pg/mL
|
Pregnenolone & Allopregnanolone Sulfates
|
LC/MS/MS
|
Human Plasma
|
250 pg/mL
|
Propranolol and Mannitol
|
LC/MS/MS
|
Krebs-Ringer Buffer
|
|
Pseudoephedrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Pterostilbene
|
LC/MS/MS
|
Human Serum
|
0.5 ng/mL
|
Pyruvic Acid
|
LC/MS/MS
|
Human Urine
|
0.05 µg/mL
|
Ranolazine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Rapastinel
|
LC/MS/MS
|
Human Plasma
|
|
Rapastinel
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
R-Baclofen and AP
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Relamorelin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Relamorelin
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
0.25 ng/mL
|
R-Ketorolac and S-Ketorolac
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
5 ng/mL
|
Roflumilast and Roflumilast N-Oxide
|
LC/MS/MS
|
Human Lithium Heparin Plasma
|
0.1 ng/mL
|
Rosuvastatin, N-Desmethyl Rosuvastatin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
Salmeterol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
Selenium
|
ICP/MS
|
Human Serum
|
100 ng/mL
|
Sepin-1
|
HPLC-UV
|
Dosing Solution
|
|
Sepin-1
|
LC/MS/MS
|
K2EDTA Rat Blood
|
|
Serotonin
|
LC/MS/MS
|
Various
|
1 ng/mL
|
Sertraline
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Sertraline (Desmethyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Short Chain Fatty Acids
|
GC/MS
|
Formulations
|
|
Silcone
|
ICP/MS
|
K2EDTA Human Plasma
|
10 µg/mL
|
Sildenafil and N-Desmethyl Sildenafil
|
LC/MS/MS
|
Sodium Heparin Human Plasma
|
1 ng/mL
|
Silicon
|
ICP-MS
|
K2EDTA Human Plasma
|
|
Silodosin and 2 Metabolites
|
|
Human Lithium Heparin Plasma
|
|
Simvastatin, Simvastatin Hydroxy Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Sitagliptin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Solifenacin and Metabolites
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
Statin
|
LC/MS/MS
|
Mouse Plasma and Mouse Muscle
|
|
Stearoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
Stearoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Sulbactam sodium and EXT2514
|
LC/MS/MS
|
Human BAL
|
2 ng/mL
|
Tebipenem
|
LC/MS/MS
|
Human BAL
|
1 ng/mL
|
Threonate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Threonic Acid
|
LC/MS/MS
|
Human Plasma
|
0.5 ug/mL
|
Thyrotropin Stimulating Hormone (TSH)
|
Immunoassay
|
Human Serum
|
0.2 µIU/mL
|
Tigecycline
|
LC/MS/MS
|
Acidified Human Cell Pellet
|
|
Tigecycline
|
LC/MS/MS
|
Human Cell Pellet
|
|
Tiotropium
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 pg/mL
|
Total T3 and T4
|
Chemiluminescent immunoassay
|
Human Serum
|
|
Total T3 and T4
|
LC/MS/MS
|
Human Serum
|
|
Triglyceride
|
Enzymatic Colorimetric Assay
|
Human Serum
|
20 mg/dL
|
TSH
|
Chemiluminescent immunoassay
|
Human Serum
|
|
Ubrogepant
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Ulipristal Acetate and N-Desmethyl Ulipristal Acetate
|
LC/MS/MS
|
Human Plasma
|
|
Ulipristal Acetate and N-Desmethyl Ulipristal Acetate
|
LC/MS/MS
|
Human Urine
|
|
Ulipristal Acetate and N-Desmethyl Ulipristal Acetate
|
LC/MS/MS
|
Protein Binding
|
|
Undecylenic Acid
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
|
Undecylenic Acid
|
LC/MS/MS
|
Mini Pig K2EDTA Plasma
|
|
Urea
|
LC/MS/MS
|
Human BAL
|
|
Urea
|
LC/MS/MS
|
Human Bronchoalveolar Lavage
|
0.2 µg/mL
|
Urea
|
LC/MS/MS
|
Human Plasma
|
|
Urea
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
Urea
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
Urea
|
LC/MS/MS
|
KOx/NaF Human Plasma
|
100 µg/mL
|
Urea
|
LC/MS/MS
|
Mice Ball
|
|
Urea
|
LC/MS/MS
|
Mice Plasma
|
|
Urea
|
LC/MS/MS
|
Mouse BAL
|
|
Urea
|
LC/MS/MS
|
Mouse Sodium Heparine Plasma
|
|
Uric Acid
|
LC/MS/MS
|
Human Tissue and Lavage Fluid
|
5 ng/mL
|
Uridine
|
LC/MS/MS
|
Human Plasma
|
0.1 µg/mL
|
Uridine, Uric Acid and cAMP
|
LC/MS/MS
|
Plasma
|
|
Valsartan
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 ng/mL
|
Venlafaxine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Venlafaxine (Desmethyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Vilazodone
|
|
Human Plasma
|
|
Vilazodone
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
2 ng/mL
|
Vilazodone
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
2 ng/mL
|
Vilazodone (M17 Metabolite)
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
1 ng/mL
|
Vilazodone (M17 Metabolite)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
1 ng/mL
|
Vildagliptin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Vitamin B6
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
Vitamin D2, 1, 25-Dihydroxy
|
LC/MS/MS
|
Human Serum
|
10 pg/mL
|
Vitamin D2, 25-Hydroxy
|
LC/MS/MS
|
Human Serum
|
5 ng/mL
|
Vitamin D3
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
Vitamin D3, 1, 25-Dihydroxy
|
LC/MS/MS
|
Human Serum
|
10 pg/mL
|
Vitamin D3, 25-Hydroxy
|
LC/MS/MS
|
Human Serum
|
5 ng/mL
|
Vitamin D3, 25-Hydroxy
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
Vortioxetine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human BAL
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human BAL AM Pellet and BAL ELF
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human Urine
|
|